-
-
-
-
-
-
-
Optimi Health Appoints Dr. Michael Blough as Chief Clinical Development Officer
-
-
-
-
-
-
-
Optimi Health ships psilocybin capsules to Australia in third export
-
-
-
-
-
-
-
Optimi Health exports psilocybin to UK for phase 2 clinical trial
-
-
-
-
-
-
-
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development
-
-
-
-
-
-
-
Optimi Health acknowledges expanded psychedelic therapy access in Australia
-
-
-
-
-
-
-
Optimi Health prices $15 million public offering, lists on NASDAQ
-
16,402 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


